Camber Capital Management LP Alkermes Plc. Transaction History

Camber Capital Management LP

$4.32 Billion
Q4 2024

A detailed history of Camber Capital Management LP transactions in Alkermes Plc. stock. As of the latest transaction made, Camber Capital Management LP holds 1,500,000 shares of ALKS stock, worth $53.3 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

1,500,000

Previous 200,000 650.0%

Holding current value

$53.3 Million

Previous $5.6 Million 670.63%

% of portfolio

1.0%

Previous 0.18%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$25.7 - $31.46 $33.4 Million - $40.9 Million	1,300,000 Added 650.0%	1,500,000 $43.1 Million
Q3 2024 Nov 14, 2024	BUY	$23.01 - $28.55 $4.6 Million - $5.71 Million	200,000 New	200,000 $5.6 Million
Q1 2022 May 16, 2022	SELL	$23.07 - $27.99 $30 Million - $36.4 Million	-1,300,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$21.47 - $32.08 $30.6 Million - $45.7 Million	-1,425,000 Reduced 52.29%	1,300,000 $30.2 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $36.8 Million - $50.6 Million	-1,575,000 Reduced 36.63%	2,725,000 $84 Million
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $24.4 Million - $32.7 Million	-1,300,000 Reduced 23.21%	4,300,000 $105 Million
Q1 2021 May 17, 2021	SELL	$18.21 - $23.2 $20.9 Million - $26.7 Million	-1,150,000 Reduced 17.04%	5,600,000 $105 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $7.7 Million - $11.1 Million	-500,000 Reduced 6.9%	6,750,000 $135 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $16 Million - $23.3 Million	1,200,000 Added 19.83%	7,250,000 $141 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $25.1 Million - $40.9 Million	1,925,000 Added 46.67%	6,050,000 $87.2 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $10.8 Million - $13.6 Million	625,000 Added 17.86%	4,125,000 $84.2 Million
Q3 2019 Nov 14, 2019	BUY	$19.51 - $24.28 $64.6 Million - $80.4 Million	3,311,719 Added 1758.92%	3,500,000 $68.3 Million
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $4.04 Million - $7.03 Million	188,281 New	188,281 $4.24 Million
Q1 2018 May 15, 2018	SELL	$53.61 - $67.26 $21.4 Million - $26.9 Million	-400,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$47.69 - $55.39 $19.1 Million - $22.2 Million	400,000	400,000 $21.9 Million

Others Institutions Holding ALKS

# of Institutions

375

Shares Held

173M

Call Options Held

231K

Put Options Held

158K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $5.83B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camber Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Camber Capital Management LP with notifications on news.

Account

Camber Capital Management LP Alkermes Plc. Transaction History